{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:17:16Z","timestamp":1792264636487,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ihj.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T16:40:39Z","timestamp":1740588039000},"page":"84-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adherence to pharmacotherapy for secondary prevention of coronary heart disease: A registry-based prospective study"],"prefix":"10.1016","volume":"77","author":[{"given":"Aradhai","family":"Bana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soneil","family":"Guptha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8356-3137","authenticated-orcid":false,"given":"Rajeev","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2025.02.009_bib1","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2025.02.009_bib2","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risk collaborators. Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2025.02.009_bib3","article-title":"Epidemiology of ischemic heart disease and diabetes in India: an overview of the twin epidemic","author":"Gupta","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.ihj.2025.02.009_bib4","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2025.02.009_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ihj.2022.11.011","article-title":"Revisiting secondary prevention in coronary heart disease","volume":"74","author":"Sigamani","year":"2022","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2025.02.009_bib6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Low use of secondary prevention medications for cardiovascular disease in the community in 17 high, middle and low-income countries (The PURE Study)","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2025.02.009_bib7","first-page":"1007","article-title":"Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India","volume":"5","author":"Sharma","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ihj.2025.02.009_bib8","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2025.02.009_bib9","series-title":"Adherence to Long Term Therapies: Evidence for Action","author":"Sabate","year":"2003"},{"key":"10.1016\/j.ihj.2025.02.009_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s11606-011-1825-3","article-title":"A systematic review of adherence to cardiovascular medications in resource-limited settings","volume":"26","author":"Bowry","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ihj.2025.02.009_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2025.02.009_bib12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ahj.2014.07.029","article-title":"Rationale and design of a randomised controlled trial in secondary prevention of acute coronary syndromes in India (SPREAD)","volume":"168","author":"Kamath","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2025.02.009_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.pcad.2013.11.001","article-title":"Cardiac rehabilitation in India","volume":"57","author":"Madan","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ihj.2025.02.009_bib14","article-title":"Association of health insurance status with cardiovascular risk factors, coronary artery disease, coronary interventions and outcomes in India","volume":"14","author":"Gupta","year":"2022","journal-title":"Int J Cardiol: Cardiovasc Risk Prev"},{"key":"10.1016\/j.ihj.2025.02.009_bib15","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/eurheartj\/ehac249","article-title":"Cardiovascular disease, mortality and their associations with modifiable risk factors in a multinational South Asia cohort: a PURE Substudy","volume":"43","author":"Joseph","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2025.02.009_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ihj.2016.03.027","article-title":"Non-physician health workers and adherence to medications and lifestyles following acute coronary syndrome: 24 month follow-up study","volume":"68","author":"Sharma","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2025.02.009_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.amjmed.2012.09.004","article-title":"The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review","volume":"126","author":"Bitton","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2025.02.009_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.clinthera.2023.08.011","article-title":"Patient adherence to secondary prevention therapies after ACS: a scoping review","volume":"45","author":"Bahit","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.ihj.2025.02.009_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/gh.1278","article-title":"World Heart Federation roadmap for secondary prevention of cardiovascular disease: 2023 update","volume":"19","author":"Lanjo","year":"2024","journal-title":"Global Heart"},{"key":"10.1016\/j.ihj.2025.02.009_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1311890","article-title":"Cardiovascular risk and events in 17 low-, middle- and high-income countries","volume":"371","author":"Yusuf","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2025.02.009_bib21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/CIRCULATIONAHA.115.008721","article-title":"Resource effective strategies to prevent and treat cardiovascular disease","volume":"133","author":"Schwalm","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2025.02.009_bib22","series-title":"Fuster & Hurst: The Heart","first-page":"511","article-title":"Location and level of care, education, availability of medicines and cardiovascular mortality","author":"Gupta","year":"2022"},{"key":"10.1016\/j.ihj.2025.02.009_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.ihj.2025.02.009_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.ihj.2025.02.009_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1185\/03007995.2012.677419","article-title":"Effect of dosing frequency on cardiovascular disease medication adherence","volume":"28","author":"Coleman","year":"2012","journal-title":"Curr Med Res Opinion"},{"key":"10.1016\/j.ihj.2025.02.009_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13375","article-title":"Assessment of studies of quality improvement strategies to enhance outcomes in patients with cardiovascular disease","volume":"4","author":"Singh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ihj.2025.02.009_bib27","first-page":"e168","article-title":"Digital health technology in cardiovascular disease prevention and rehabilitation","volume":"6","author":"Sigamani","year":"2022","journal-title":"J Cardiac Pulmonary Rehabilitation"},{"key":"10.1016\/j.ihj.2025.02.009_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurheartj\/ehq297","article-title":"Strategies to improve drug adherence","volume":"32","author":"Laufs","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2025.02.009_bib29","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1093\/eurheartj\/ehae465","article-title":"Artificial intelligence in cardiovascular medicine: clinical applications","volume":"456","author":"Luscher","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2025.02.009_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155,722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2025.02.009_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1454-y","article-title":"Challenges in ischemic heart disease management and prevention in low socioeconomic status people in low and lower-middle income countries","volume":"17","author":"Gupta","year":"2019","journal-title":"BMC Med"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483225000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483225000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T16:43:29Z","timestamp":1747759409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483225000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0019483225000446"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2025.02.009","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to pharmacotherapy for secondary prevention of coronary heart disease: A registry-based prospective study","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}